Deversify Health AB
DEV | ST
Overview
Corporate Details
- ISIN(s):
- SE0015660345 (+3 more)
- LEI:
- 549300498ZGZ1NBYC361
- Country:
- Sweden
- Address:
- Skeppsbron 34,, 111 30 Stockholm
- Website:
- https://deversify.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Deversify Health AB was a Swedish health technology company specializing in research, development, and commercialization of solutions for personalized health. The company's primary focus was on mobile electronic breathalyzers, such as its flagship Acetrack device, and accompanying software applications designed to monitor biomarkers related to metabolic health. Its target markets included consumers, businesses, and healthcare providers. In addition to its hardware platform for breath analysis, Deversify offered educational services and programs centered on personal nutrition and wellness through its Elitista platform, acquired in 2021. Following a reverse acquisition by Euroafrica Digital Ventures in early 2024, the company was declared bankrupt and delisted from the Nasdaq First North Growth Market in November 2024.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Deversify Health AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Deversify Health AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Deversify Health AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
